CHRN
NASDAQ
Health Care
$26.43
USD
+$0.72 (+2.80%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$3.56B
Volume:
365.6K
Previous Close
$25.71
Day Range
$22.25 - $26.86
52 Week Range
$12.27 - $30.00
Average Volume (10 Days)
430.0K
P/E Ratio (TTM)
—
Dividend Yield
—
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
CEO
Mr. Scott Davis
Headquaters
San Rafael California, CALIFORNIA, US
Founded
2013
Employees
50
ATRC
AtriCure Inc
$34.95
-1.9%
AXGN
AxoGen Inc
$39.85
+0.2%